Press Releases

Date	Title	Company
01-Aug-2022	Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial	Businesswire
01-Aug-2022	PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY	PAION AG
01-Aug-2022	Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic	Businesswire
01-Aug-2022	BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology	B3C newswire
01-Aug-2022	MRI – Compatible IV Infusion Pump Systems Market is increasing at a value CAGR of 7.1% over the forecast period by 2027	MARKITWIRED
01-Aug-2022	Cancer Tissue Diagnostics Market will expand at a healthy CAGR of 8.3% during the forecast period by 2031	MARKITWIRED
01-Aug-2022	Varicose Vein Treatment Market is likely to secure a CAGR of 6.2% forecast period by 2032	MARKITWIRED
01-Aug-2022	Surgical Stapling Devices Market is expected to reach US$ 6.2 Billion by 2031	MARKITWIRED
01-Aug-2022	Widefield Imaging Systems Market is projected to exhibit a CAGR of 8.6% forecast period by 2031	MARKITWIRED
01-Aug-2022	HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022	MARKITWIRED
01-Aug-2022	Paediatric Spasticity Treatment Market is likely to register a CAGR of 10% during the forecast period 2022-2032	MARKITWIRED
01-Aug-2022	Dental Chairs Market is expected to reach US$ 851 Million by 2032	MARKITWIRED
01-Aug-2022	China Spinal Fusion Market Key Players : Trauson, Depuy Synthes Companies, Biomet, Inc., Medtronic, Inc, Nuvasive Inc.	MARKITWIRED
01-Aug-2022	Thyroid Function Tests Market is anticipated to grow at an average rate with a CAGR of 4.2 % from 2022-2032.	MARKITWIRED
01-Aug-2022	IVD Antibodies Market size is projected to grow at a healthy CAGR of around 7% from 2022 and 2032	MARKITWIRED
31-Jul-2022	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022 (news with additional features)	Vivoryon Therapeutics N.V.
31-Jul-2022	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O (news with additional features)	Vivoryon Therapeutics N.V.
30-Jul-2022	Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements	Dermapharm Holding SE
30-Jul-2022	Dermapharm Holding SE: binding offer to acquire Arkopharma Group	Dermapharm Holding SE
29-Jul-2022	Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox	Bavarian Nordic